Lilly To Bring Forward Alzheimer’s Readout
Gamble By Rivals Biogen Is Likely Inspiration
After years of failure, expectations of solanezumab are very low – but Lilly still hoping for a signal.
After years of failure, expectations of solanezumab are very low – but Lilly still hoping for a signal.